United States Antimony Corp (AMEX:UAMY) does about 2.48M shares in volume on a normal day but saw 1069869 shares change hands in the recent trading day. The company now has a market cap of 184.36M USD. Its current market price is $1.70, marking a decrease of -1.16% compared to the previous close of $1.72. The 52 week high reached by this stock is $2.35 whilst the lowest price level in 52 weeks is $0.21.
United States Antimony Corp (UAMY) has a 20-day trading average at $1.4955 and the current price is -27.66% off the 52-week high compared with 709.52% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.6602 and its 200-day simple moving average is $0.9417. If we look at the stock’s price movements over the week, volatility stands at 7.40%, which increases to 10.04% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 56.12 to suggest the stock is neutral.
The consensus objective for the share price is $2.62, suggesting that the stock has a potential upside of 35.11% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on December 10, 2024 when H.C. Wainwright initiated the stock to “Buy” and issued a price target of $2.50.
The current price level is 13.67%, 2.40%, and 80.53% away from its SMA20, SMA50, and SMA200 respectively, with the UAMY price moving below the 50-day SMA on current market day. United States Antimony Corp (UAMY) stock is up 18.06% over the week and -10.53% over the past month. Its price is -3.95% year-to-date and 593.88% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year. Expected sales for next quarter are $8.04M, which analysts say will come at $13.87M for the current fiscal year and next year at $40.83M. In addition, estimates put the company’s current quarterly revenue at an average of $4.47M.
To reach the target analysts have set, the stock logically needs to grow 35.11 percent from here.
Outstanding shares total 108.44M with insiders holding 23.71% of the shares and institutional holders owning 20.09% of the company’s common stock. The company has a return on investment of -17.21% and return on equity of -15.54%. The forward price to earnings ratio is 30.91. The beta has a value of 0.41. Price to book ratio is 7.34 and price to sales ratio is 18.95.
